Home » Topics » BioWorld Science, Immune

BioWorld Science, Immune
RSS

DNA-based Mayaro virus vaccine protects mice from virus challenge

Feb. 14, 2019

Phase I interim data show mRNA-1653 boosts serum neutralization titers against hMPV and PIV3

Feb. 13, 2019

Enrollment ongoing in phase I study of CRV-101 vaccine candidate

Feb. 13, 2019

Alpine initiates first-in-human trial of dual ICOS/CD28 antagonist ALPN-101

Feb. 11, 2019

Same compound inhibits wild-type, activates mutant MALT1

Feb. 7, 2019

Kamada reports interim data from phase II study of IV-AAT to prevent lung transplant rejection

Feb. 6, 2019

Genentech and NewLink Genetics identify TDO inhibitors

Feb. 6, 2019

VIB-9600 demonstrates promising activity and safety in preclinical models of autoimmune disease

Feb. 6, 2019

DSMB gives positive safety review for phase II HERACLES study of MaaT-013

Feb. 6, 2019

GlaxoSmithKline initiates phase I study of GSK-3844766A vaccine

Feb. 5, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...